Jump to content

Diane Finegood

Add links
From Wikipedia, the free encyclopedia
Diane Finegood
Finegood in 2011
Academic background
EducationBSc, Engineering, 1978, University of Michigan
MSc, Engineering, 1979, Northwestern University
PhD, Physiology and Biophysics, 1984, University of Southern California
ThesisThe minimal model approach to in vivo assessment of metabolic status: a validation and application to growth hormone-induced glucose intolerance (1984)
Academic work
InstitutionsSimon Fraser University

Diane Terri Finegood is an American–Canadian kinesiologist, chemical and biomedical engineer, and physiologist. Finegood was elected a Fellow of the Canadian Academy of Health Sciences in 2007.

Early life and education

[edit]

Finegood completed her bachelor's degree in chemical engineering from the University of Michigan and her master's degree in biomedical engineering from Northwestern University. Following this, she obtained her PhD in physiology and biophysics from the University of Southern California in 1984.[1]

Career

[edit]

From 1984 to 1986, Finegood was a postdoctoral fellow in the laboratory of Mladen Vranic at the University of Toronto.[2] From 1987 to 1996, Finegood was on faculty at the University of Alberta[3] where she continued her basic science research on diabetes and metabolic physiology and began work with the islet transplant group[4] on a basic science research program.[5] In 1996, Finegood moved from the University of Alberta to Simon Fraser University where her research expanded from the pathophysiology of type 2 diabetes to include work on type 1 diabetes. A few years later, her research team received one of two Juvenile Diabetes Foundation/Medical Research Council Diabetes Research Partnership grants.[6] With this funding, Finegood began investigating the earliest stages of the immune system's attack on insulin-making beta cells in those with type 1 diabetes.

Finegood in 2003

Finegood has received many honours and awards throughout her career. In 1995, Finegood received Diabetes Canada's Young Scientist Award for the purpose of encouraging "outstanding research conducted in Canada by young scientists in the field of diabetes.".[7] In 2001, she was recognized with the B.C. Sugar Achievement award as someone who has "brought distinction to the university and B.C. by achieving national and international recognition."[8] and in 2002 a Woman of Distinction award "for her ground-breaking diabetes research on the onset of juvenile and adult diabetes."[9] Finegood was later recognized as a Trailblazer & Trendsetter in the 2006 Top 100 Canada's Most Powerful Women.[10] In 2007, she was elected a Fellow of the Canadian Academy of Health Sciences.[11] She also received the 2008 Frederick G. Banting Award from Diabetes Canada for her contributions to obesity and diabetes.[12]

In 2000, Finegood was appointed as the inaugural scientific director of the CIHR Institute if Nutrition, Metabolism and Diabetes.[13] In this role, Finegood began directing research funds towards the obesity epidemic.[14][15] Her focus on obesity led her to establish[16] a novel public-private collaboration called Canada on the Move with Kellogg Canada.[17] During her time as scientific director, she evolved her academic pursuits towards public-private partnership,[18] systems thinking.[19] and complexity.[20] She stepped down as scientific director in 2008 after serving in the role for eight years.[21]

In 2011, Finegood was appointed president and CEO of the Michael Smith Foundation for Health Research[22] where she was responsible for raising $140 million in funding from the provincial government and led the development of a provincial health research strategy.[23] In 2017, she returned to the Simon Fraser University where she is a professor and fellow in the Morris J. Wosk Centre for Dialogue.[24] She continues to work on systems approaches to complex challenges,[25] serves on a number of scientific advisory boards,[26][27] and is applying dialogue approaches to public engagement on a national framework for diabetes.[28]

References

[edit]
  1. ^ "DR. DIANE FINEGOOD". sfu.ca. Retrieved May 10, 2021.
  2. ^ Brubaker, Patricia. "Humour, Patience and Brilliance: A Personal Reflection on the Late Mladen Vranic". Retrieved 30 December 2022.
  3. ^ Finegood, Diane. "Experience". Linked In. Retrieved 30 December 2022.
  4. ^ Rutherford, Gillian. "Sweet Success". University of Alberta. Retrieved 30 December 2022.
  5. ^ "Publications". Google Scholar. Retrieved 30 December 2022.
  6. ^ Procter, Sharon J (May 2003). "DIABETES: Diane Finegood sets Canada's research agenda". Aq: The Magazine of Simon Fraser University: 14–16.
  7. ^ "Young scientist award". diabetes.ca. Retrieved May 9, 2021.
  8. ^ Thorbes, Carol (October 18, 2001). "Finegood takes B.C. Sugar award". sfu.ca. Retrieved May 10, 2021.
  9. ^ "Women of Distinction". sfu.ca. June 27, 2002. Retrieved May 10, 2021.
  10. ^ "Trent University President Bonnie Patterson named One of Canada's Most Powerful Women". trentu.ca. November 21, 2006. Retrieved May 10, 2021.
  11. ^ "Finegood, Diane". cahs-acss.ca. Retrieved May 10, 2021.
  12. ^ "Finegood wins Banting award". sfu.ca. October 30, 2008. Retrieved May 10, 2021.
  13. ^ "CIHR seeking firm funding commitment as momentum builds at Canada's premier health research funding agency". Research Money. Retrieved 30 December 2022.
  14. ^ Meadahl, Marianne (May 15, 2003). "Researchers tackle obesity". sfu.ca. Retrieved May 10, 2021.
  15. ^ Wysong, Pippa (April 2004). "Institute for Nutrition, Metabolism and Diabetes". Clinical and Investigative Medicine. 27 (2): 67–69. PMID 15202825. ProQuest 196421312. Retrieved 1 January 2023.
  16. ^ Rose, Adria; Finegood, Diane (March 2006). "Postscript: Learning from the experience of developing and running Canada on the Move" (PDF). Canadian Journal of Public Health. 97: S41–S42. doi:10.1007/BF03405364. PMC 6975677. PMID 16676838.
  17. ^ Deitz, William H. (March 2006). "Canada on the Move: A Novel Effort to Increase Physical Activity Among Canadians". Canadian Journal of Public Health. 97: S3-4. PMID 16676831. ProQuest 231996383.
  18. ^ Johnston, Lee M.; Finegood, Diane T. (March 2015). "Cross-Sector Partnerships and Public Health: Challenges and Opportunities for Addressing Obesity and Noncommunicable Diseases Through Engagement with the Private Sector". Annual Review of Public Health. 36: 255–271. doi:10.1146/annurev-publhealth-031914-122802. PMID 25581149.
  19. ^ Morgans, Liz. "Complex is not the same as complicated!". C3 Collaborating for Health. Retrieved 1 January 2023.
  20. ^ Finegood, Diane; MacLeod, Hugh. "Blurring the Lines between Research, Evaluation and Quality Improvement". Longwoods.com. Retrieved 1 January 2023.
  21. ^ "Dr. Philip M. Sherman Appointed Scientific Director of CIHR's Institute of Nutrition, Metabolism and Diabetes". canada.ca. October 20, 2008. Retrieved May 10, 2021.
  22. ^ "Dr. Diane Finegood appointed MSFHR President and CEO". Faculty of Medicine. The University of British Columbia. Retrieved 1 January 2023.
  23. ^ MSFHR. "Leadership Announcement". Office of Research Services. Simon Fraser University. Retrieved 1 January 2023.
  24. ^ Finegood, Diane. "Systems Thinking in Health". Simon Fraser University. Retrieved 30 December 2022.
  25. ^ Jebb, Susan; Finegood, Diane. "Systems-based approaches in public health: Where next?". Canadian Academy of Health Sciences. Retrieved 1 January 2023.
  26. ^ "Professor Diane Finegood: Scientific Advisory Committee". The Australian Prevention Partnership Centre. Retrieved 1 January 2023.
  27. ^ "Governance". UKPRP Prevention Research Partnership. Medical Research Council. Retrieved 1 January 2023.
  28. ^ "Informing a Framework for Diabetes in Canada: Stakeholder Engagement Summary". Government of Canada. Retrieved 1 January 2023.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Diane_Finegood&oldid=1226742592"